Retina/Vitreous

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...

A pioneering gene therapy trial reported in The Lancet by Prof Michel Michaelides (UCL Institute of Ophthalmology and Moorfields Eye Hospital), Dr Yannik Laich and colleagues at Moorfields Eye Hospital and Great Ormond Street Hospital for Children (London, UK), has shown life-changing visual improvements in children with Leber Congenital Amaurosis type 4 (LCA4), a rare and severe inherited retinal dystrophy caused by mutations in the AIPL1 gene.1  Infants with pathogenic variants in the AIPL1 gene experience severe and rapidly progressive vision loss starting at birth.

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Two experts discuss the identification of patients with geographic atrophy and advances in its management.

A pioneering gene therapy has shown promising results in restoring sight in young children with AIPL1-associated severe retinal dystrophy—an ultra-rare genetic condition that causes profound sight impairment from birth and, until now, had no existing treatment. The findings, published in The Lancet, mark a major step forward in tackling inherited blindness.

This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.

Watch a retina specialist discuss newly available treatments for AMD and DMO